Loading...

Ipsen S.A.

IPSEYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$29.77
$1.12(3.91%)

Ipsen S.A. IPSEY Peers

See (IPSEY) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
IPSEY$29.78+3.91%39.4B24.41$1.22+0.75%
MKGAF$132.80+3.90%57.7B17.80$7.46+1.70%
MKKGY$26.04+2.64%57.1B17.48$1.49+2.23%
HLNCF$5.25+1.16%47.2B24.98$0.21+1.17%
TKPHF$28.35+2.42%44.6B60.32$0.47+4.81%
SDZNY$52.66-1.42%22.7B-2633.00-$0.02+1.28%
TEVJF$17.80N/A20.4B-15.48-$1.15N/A
ESALY$61.51-2.11%17.6B20.54$3.00N/A
SGIOF$17.63N/A15B12.77$1.38+2.36%
SGIOY$8.75+1.27%14.9B12.68$0.69+1.82%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

IPSEY vs MKGAF Comparison

IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IPSEY stands at 39.4B. In comparison, MKGAF has a market cap of 57.7B. Regarding current trading prices, IPSEY is priced at $29.78, while MKGAF trades at $132.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IPSEY currently has a P/E ratio of 24.41, whereas MKGAF's P/E ratio is 17.80. In terms of profitability, IPSEY's ROE is +0.17%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, IPSEY is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.

Stock Price Comparison

Loading...

Frequently Asked Questions

;